HLA-C*03:04:01 and HLA-B*15:18:01 but not HLA-DQA1*05 associated with anti- tumor necrosis factor antibody formation in Taiwanese inflammatory bowel disease patients

doi:10.3748/wjg.v31.i41.111745

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 31, Issue 41

This Article

(42)

(58)

(0)

(8)

(821)

(3)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Gastroenterol. Nov 7, 2025; 31(41): 111745
Published online Nov 7, 2025. doi: 10.3748/wjg.v31.i41.111745

Full Size Figure Download Figure

Figure 1 Drug persistence of biologic agents. A: Overall inflammatory bowel disease cohort; B: Crohn’s disease cohort. Both determined according to a Kruskal-Wallis test; C: Kaplan-Meier analysis with log-rank test comparing drug persistence among biologic agents in the inflammatory bowel disease cohort.

Citation: Weng MT, Yao CY, Lin WC, Lai SK, Tung CC, Wang CY, Wong JM, Chen PL, Wei SC. HLA-C*03:04:01 and HLA-B*15:18:01 but not HLA-DQA1*05 associated with anti- tumor necrosis factor antibody formation in Taiwanese inflammatory bowel disease patients. World J Gastroenterol 2025; 31(41): 111745
URL: https://www.wjgnet.com/1007-9327/full/v31/i41/111745.htm
DOI: https://dx.doi.org/10.3748/wjg.v31.i41.111745

Weng MT, Yao CY, Lin WC, Lai SK, Tung CC, Wang CY, Wong JM, Chen PL, Wei SC. HLA-C03:04:01 and HLA-B*15:18:01 but not HLA-DQA1*05 associated with anti- tumor necrosis factor antibody formation in Taiwanese inflammatory bowel disease patients. World J Gastroenterol* 2025; 31(41): 111745 [PMID: 41257274 DOI: 10.3748/wjg.v31.i41.111745]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.